BCAS1 and glioblastoma: Because β-arrestin 2 is an interaction partner of BCAS1-SV1, we speculate that BCAS1-SV1 may enhance GBM development by binding to β-arrestin 2 and by hindering its function, resulting in the loss of ability of β-arrestin 2 to prevent cell proliferation and migration.